Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: Implications for intrahepatic grafts

Journal of Leukocyte Biology

Volumn 77, Issue 5, 2005, Pages 587-597

  Barshes, Neal R ^a   Wyllie, Samuel ^a   Goss, John A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokines; Ischemia reperfusion; Kupffer cell; Portal vein

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; FREE RADICAL; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; L SELECTIN; NITRIC OXIDE;

ANGIOGENESIS; APOPTOSIS; ARTERY BLOOD FLOW; CYTOKINE RELEASE; CYTOTOXICITY; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIA; KUPFFER CELL; LIVER CELL; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET TRANSPLANTATION; PORTAL VEIN BLOOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CYCLOOXYGENASE 2; GRAFT SURVIVAL; HEPATOCYTES; HUMANS; INFLAMMATION; INTERLEUKIN-1; ISLETS OF LANGERHANS TRANSPLANTATION; KUPFFER CELLS; MEMBRANE PROTEINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; UP-REGULATION;

EID: 18244364592     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1104649     Document Type: Review

References (149)

1. Shapiro, A. M., Lakey, J. R., Ryan, E. A., Korbutt, G. S., Toth, E., Warnock, G. L., Kneteman, N. M., Rajotte, R. V. (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230-238.
2. Barshes, N. R., Lee, T., Goodpasture, S., Brunicardi, F. C., Alejandro, R., Ricordi, C., Soltes, G., Barth, M., Hamilton, D., Goss, J. A. (2004) Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review. Transplant. Proc. 36, 1127-1129.
3. Osama, G. A., Chamsuddin, A., Fraga, D., Fisher, J., Lo, A. (2004) Insulin independence achieved using the transmesenteric approach to the portal vein for islet transplantation. Transplantation 77, 309-311.
4. Ballinger, W. F., Lacy, P. E. (1972) Transplantation of intact pancreatic islets in rats. Surgery 72, 175-186.
5. London, N. J., Robertson, G. S., Chadwick, D. R., Johnson, P. R., James, R. F., Bell, P. R. (1994) Human pancreatic islet isolation and transplantation. Clin. Transplant. 8, 421-459.
6. Goss, J. A., Schock, A. P., Brunicardi, F. C., Goodpastor, S. E., Garber, A. J., Soltes, G., Barth, M., Froud, T., Alejandro, R., Ricordi, C. (2002) Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center. Transplantation 74, 1761-1766.
7. Markmann, J. F., Deng, S., Huang, X., Desai, N. M., Velidedeoglu, E. H., Lui, C., Frank, A., Markmann, E., Palanjian, M., Brayman, K., Wolf, B., Bell, E., Vitamaniuk, M., Doliba, N., Matschinsky, F., Barker, C. F., Naji, A. (2003) Insulin independence following isolated islet transplantation and single islet infusions. Ann. Surg. 237, 741-749.
8. Kenmochi, T., Mullen, Y., Miyamoto, M., Stein, E. (1994) Protection of mouse islet isografts from early transplantation damage by nicotinamide treatment of recipients. Transplant. Proc. 26, 693.
9. Bottino, R., Fernandez, L. A., Ricordi, C., Lehmann, R., Tsan, M. F., Oliver, R., Inverardi, L. (1998) Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 47, 316-323.
10. Mandrup-Poulsen, T., Spinas, G. A., Prowse, S. J., Hansen, B. S., Jorgensen, D. W., Bendtzen, K., Nielsen, J. H., Nerup, J. (1987) Islet cytotoxicity of interleukin 1. Influence of culture conditions and islet donor characteristics. Diabetes 36, 641-647.
11. Nagata, M., Mullen, Y., Matsuo, S., Herrera, M., Clare-Salzler, M. (1990) Destruction of islet isografts by severe nonspecific inflammation. Transplant. Proc. 22, 855-856.
12. Alejandro, R., Cutfield, R. G., Shienvold, F. L., Polonsky, K. S., Noel, J., Olson, L., Dillberger, J., Miller, J., Mintz, D. H. (1986) Natural history of intrahepatic canine islet cell autografts. J. Clin. Invest. 78, 1339-1348.
13. Biarnes, M., Montolio, M., Nacher, V., Raurell, M., Soler, J., Montanya, E. (2002) β-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 51, 66-72.
14. Kaufman, D. B., Platt, J. L., Rabe, F. L., Dunn, D. L., Bach, F. H., Sutherland, D. E. (1990) Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J. Exp. Med. 172, 291-302.
15. Kaufman, D. B., Gores, P. F., Field, M. J., Farney, A. C., Gruber, S. A., Stephanian, E., Sutherland, D. E. (1994) Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass. Diabetes 43, 778-783.
16. Tran, P. O., Gleason, C. E., Robertson, R. P. (2002) Inhibition of interleukin-1β-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet β-cell function. Diabetes 51, 1772-1778.
17. Poggioli, R., Molano, R. D., Pileggi, A., Zahr, E., Ricordi, C., Inverardi, L. (2003) Selective inhibition of COX-2 results in improved islet graft function. Am. J. Transplant. 3 (Suppl. 5), 208.
18. Mandrup-Poulsen, T. (2001) β-cell apoptosis: stimuli and signaling. Diabetes 50 (Suppl. 1), S58-S63.
19. Paraskevas, S., Duguid, W. P., Maysinger, D., Feldman, L., Agapitos, D., Rosenberg, L. (1997) Apoptosis occurs in freshly isolated human islets under standard culture conditions. Transplant. Proc. 29, 750-752.
20. Thomas, F. T., Hutchings, A., Contreras, J., Wu, J., Jiang, X. L., Eckhoff, D., Thomas, J. M. (2002) Islet transplantation in the twenty-first century. Immunol. Res. 26, 289-296.
21. Mandrup-Poulsen, T. (1996) The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39, 1005-1029.
22. Montgomery, K. F., Osborn, L., Hession, C., Tizard, R., Goff, D., Vassallo, C., Tarr, P. I., Bomsztyk, K., Lobb, R., Harlan, J. M. (1991) Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc. Natl. Acad. Sci. USA 88, 6523-6527.
23. Tran, P. O., Gleason, C. E., Poitout, V., Robertson, R. P. (1999) Prostaglandin E(2) mediates inhibition of insulin secretion by interleukin-1β. J. Biol. Chem. 274, 31245-31248.
24. Grilli, M., Chiu, J. J., Lenardo, M. J. (1993) NF-κ B and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143, 1-62.
25. Nathan, C. F. (1987) Secretory products of macrophages. J. Clin. Invest. 79, 319-326.
26. Bendtzen, K., Mandrup-Poulsen, T., Nerup, J., Nielsen, J. H., Dinarello, C. A., Svenson, M. (1986) Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232, 1545-1547.
27. Xenos, E. S., Stevens, R. B., Sutherland, D. E., Lokeh, A., Ansite, J. D., Casanova, D., Gores, P. F., Platt, J. L. (1994) The role of nitric oxide in IL-1 β-mediated dysfunction of rodent islets of Langerhans. Implications for the function of intrahepatic islet grafts. Transplantation 57, 1208-1212.
28. Corbett, J. A., Kwon, G., Marino, M. H., Rodi, C. P., Sullivan, P. M., Turk, J., McDaniel, M. L. (1996) Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. Am. J. Physiol. 270, C1581-C1587.
29. Eder, J. (1997) Tumour necrosis factor α and interleukin 1 signalling: do MAPKK kinases connect it all? Trends Pharmacol. Sci. 18, 319-322.
30. Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., Goeddel, D. V. (1996) TRAF6 is a signal transducer for interleukin-1. Nature 383, 443-446.
31. Kwon, G., Corbett, J. A., Hauser, S., Hill, J. R., Turk, J., McDaniel, M. L. (1998) Evidence for involvement of the proteasome complex (26S) and NFκB in IL-1β-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes 47, 583-591.
32. Palombella, V. J., Rando, O. J., Goldberg, A. L., Maniatis, T. (1994) The ubiquitin-proteasome pathway is required for processing the NF-κ B1 precursor protein and the activation of NF-κ B. Cell 78, 773-785.
33. Kopp, E., Ghosh, S. (1994) Inhibition of NF-κ B by sodium salicylate and aspirin. Science 265, 956-959.
34. Degitz, K., Li, L. J., Caughman, S. W. (1991) Cloning and characterization of the 5′-transcriptional regulatory region of the human intercellular adhesion molecule 1 gene. J. Biol. Chem. 266, 14024-14030.
35. Wachlin, G., Augstein, P., Schroder, D., Kuttler, B., Kloting, I., Heinke, P., Schmidt, S. (2003) IL-1β, IFN-γ and TNF-α increase vulnerability of pancreatic β cells to autoimmune destruction. J. Autoimmun. 20, 303-312.
36. Xie, Q. W., Whisnant, R., Nathan, C. (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide. J. Exp. Med. 177, 1779-1784.
37. Leung, K., Betts, J. C., Xu, L., Nabel, G. J. (1994) The cytoplasmic domain of the interleukin-1 receptor is required for nuclear factor-κ B signal transduction. J. Biol. Chem. 269, 1579-1582.
38. Park, C., Kim, J. R., Shim, J. K., Kang, B. S., Park, Y. G., Nam, K. S., Lee, Y. C., Kim, C. H. (1999) Inhibitory effects of streptozotocin, tumor necrosis factor-α, and interleukin-1β on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase. Arch. Biochem. Biouhys. 362, 217-224.
39. Unger, R. H. (1991) Diabetic hyperglycemia: link to impaired glucose transport in pancreatic β cells. Science 251, 1200-1205.
40. Delaney, C. A., Pavlovic, D., Hoorens, A., Pipeleers, D. G., Eizirik, D. L. (1997) Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 138, 2610-2614.
41. Yamamoto, H., Sugitani, A., Kitada, H., Arima, T., Nishiyama, K., Motoyama, K., Shiiba, M., Kawano, R., Morisaki, T., Nakafusa, Y., Tanaka, M. (2001) Effect of FR167653 on pancreatic ischemia-reperfusion injury in dogs. Surgery 129, 309-317.
42. Cailleau, C., Diu-Hercend, A., Ruuth, E., Westwood, R., Carnaud, C. (1997) Treatment with neutralizing antibodies specific for IL-1β prevents cyclophosphamide-induced diabetes in nonobese diabetic mice. Diabetes 46, 937-940.
43. Corbett, J. A., Sweetland, M. A., Wang, J. L., Lancaster Jr., J. R., McDaniel, M. L. (1993) Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl. Acad. Sci. USA 90, 1731-1735.
44. Eizirik, D. L., Sandler, S., Welsh, N., Cetkovic-Cvrlje, M., Nieman, A., Geller, D. A., Pipeleers, D. G., Bendtzen, K., Hellerstrom, C. (1994) Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J. Clin. Invest. 93, 1968-1974.
45. Sekine, N., Ishikawa, T., Okazaki, T., Hayashi, M., Wollheim, C. B., Fujita, T. (2000) Synergistic activation of NF-κab and inducible isoform of nitric oxide synthase induction by interferon-γ and tumor necrosis factor-α in INS-1 cells. J. Cell. Physiol. 184, 46-57.
46. Chang, I., Kim, S., Kim, J. Y., Cho, N., Kim, Y. H., Kim, H. S., Lee, M. K., Kim, K. W., Lee, M. S. (2003) Nuclear factor κB protects pancreatic β-cells from tumor necrosis factor-α-mediated apoptosis. Diabetes 52, 1169-1175.
47. Stephens, L. A., Thomas, H. E., Ming, L., Grell, M., Darwiche, R., Volodin, L., Kay, T. W. (1999) Tumor necrosis factor-α-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic β cells. Endocrinology 140, 3219-3227.
48. Nussler, A. K., Carroll, P. B., Di Silvio, M., Rilo, H. L., Simmons, R. L., Starzl, T. E., Ricordi, C. (1992) Hepatic nitric oxide generation as a putative mechanism for failure of intrahepatic islet cell grafts. Transplant. Proc. 24, 2997.
49. Palmer, J. P., Helqvist, S., Spinas, G. A., Molvig, J., Mandrup-Poulsen, T., Andersen, H. U., Nerup, J. (1989) Interaction of β-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 38, 1211-1216.
50. Corbett, J. A., McDaniel, M. L. (1995) Intraislet release of interleukin 1 inhibits β cell function by inducing β cell expression of inducible nitric oxide synthase. J. Exp. Med. 181, 559-568.
51. Southern, C., Schulster, D., Green, I. C. (1990) Inhibition of insulin secretion by interleukin-1 β and tumor necrosis factor-α via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett. 276, 42-44.
52. Welsh, N., Eizirik, D. L., Bendtzen, K., Sandler, S. (1991) Interleukin-1 β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129, 3167-3173.
53. Delaney, C. A., Green, M. H., Lowe, J. E., Green, I. C. (1993) Endogenous nitric oxide induced by interleukin-1 β in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the 'comet' assay. FEBS Lett. 333, 291-295.
54. Steller, H. (1995) Mechanisms and genes of cellular suicide. Science 267, 1445-1449.
55. Xie, Q., Nathan, C. (1994) The high-output nitric oxide pathway: role and regulation. J. Leukoc. Biol. 56, 576-582.
56. Stevens, R. B., Lokeh, A., Ansite, J. D., Field, M. J., Gores, P. F., Sutherland, D. E. (1994) Role of nitric oxide in the pathogenesis of early pancreatic islet dysfunction during rat and human intraportal islet transplantation. Transplant. Proc. 26, 692.
57. Herschman, H. R. (1996) Prostaglandin synthase 2. Biochim. Biophys. Acta 1299, 125-140.
58. Sorli, C. H., Zhang, H. J., Armstrong, M. B., Rajotte, R. V., Maclouf, J., Robertson, R. P. (1998) Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc. Natl. Acad. Sci. USA 95, 1788-1793.
59. Xie, W., Merrill, J. R., Bradshaw, W. S., Simmons, D. L. (1993) Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog. Arch. Biochem. Biophys. 300, 247-252.
60. Robertson, R. P., Chen, M. (1977) A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus. J. Clin. Invest. 60, 747-753.
61. Arakawa, T., Laneuville, O., Miller, C. A., Lakkides, K. M., Wingerd, B. A., DeWitt, D. L., Smith, W. L. (1996) Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells. Structure and expression of the murine prostaglandin EP4 receptor gene. J. Biol. Chem. 271, 29569-29575.
62. Arita, S., Une, S., Ohtsuka, S., Kawahara, T., Kasraie, A., Smith, C. V., Mullen, Y. (2001) Increased islet viability by addition of beraprost sodium to collagenase solution. Pancreas 23, 62-67.
63. Arita, S., Kasraie, A., Une, S., Ohtsuka, S., Kawahara, T., Smith, C. V., Mullen, Y. (1999) Improved recovery of cryopreserved canine islets by use of beraprost sodium. Pancreas 19, 289-296.
64. Hearse, D. J., Manning, A. S., Downey, J. M., Yellon, D. M. (1986) Xanthine oxidase: a critical mediator of myocardial injury during ischemia and reperfusion? Acta Physiol. Scand. Suppl. 548, 65-78.
65. Southorn, P. A., Powis, G. (1988) Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clin. Proc. 63, 381-389.
66. Ar'Rajab, A., Dawidson, I. (1994) Ischemia-reperfusion injury in pancreas organ transplantation. In Reperfusion Injury and Clinical Capillary Leak Syndrome (B. A. Zikria, M. O. Oz, eds.), Armonk, NY, Futura, 341-354.
67. Malaisse, W. J., Malaisse-Lagae, F., Sener, A., Pipeleers, D. G. (1982) Determinants of the selective toxicity of alloxan to the pancreatic B cell. Proc. Natl. Acad. Sci. USA 79, 927-930.
68. Lenzen, S., Drinkgern, J., Tiedge, M. (1996) Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic. Biol. Med. 20, 463-466.
69. Hotta, M., Tashiro, F., Ikegami, H., Niwa, H., Ogihara, T., Yodoi, J., Miyazaki, J. (1998) Pancreatic β cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J. Exp. Med. 188, 1445-1451.
70. Kubisch, H. M., Wang, J., Luche, R., Carlson, E., Bray, T. M., Epstein, C. J., Phillips, J. P. (1994) Transgenic copper/zinc superoxide dismutase modulates susceptibility to type 1 diabetes. Proc. Natl. Acad. Sci. USA 91, 9956-9959.
71. Hohmeier, H. E., Thigpen, A., Tran, V. V., Davis, R., Newgard, C. B. (1998) Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1β- induced cytotoxicity and reduces nitric oxide production. J. Clin. Invest. 101, 1811-1820.
72. Benhamou, P. Y., Moriscot, C., Richard, M. J., Beatrix, O., Badet, L., Pattou, F., Kerr-Conte, J., Chroboczek, J., Lemarchand, P., Halimi, S. (1998) Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia 41, 1093-1100.
73. Winter, D. T., Eich, T., Jahr, H., Brendel, M. D., Bretzel, R. G. (2002) Influence of antioxidant therapy on islet graft survival. Transplant. Proc. 34, 2366-2368.
74. Biozzi, G., Benacerraf, B., Halpern, B. (1953) Quantitative study of the granulopectic activity of the reticulo-endothelial system. II. A study of the kinetics of the R. E. S. in relation to the dose of carbon injected; relationship between the weight of the organs and their activity. Br. J. Exp. Pathol. 34, 441-457.
75. Decker, K. (1990) Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192, 245-261.
76. Billiar, T. R., Curran, R. D., Stuehr, D. J., West, M. A., Bentz, B. G., Simmons, R. L. (1989) An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J. Exp. Med. 169, 1467-1472.
77. Caldwell-Kenkel, J. C., Currin, R. T., Tanaka, Y., Thurman, R. G., Lemasters, J. J. (1991) Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology 13, 83-95.
78. Clayton, H. A., Davies, J. E., Sutton, C. D., Bell, P. R., Dennison, A. R. (2001) A coculture model of intrahepatic islet transplantation: activation of Kupffer cells by islets and acinar tissue. Cell Transplant. 10, 101-108.
79. Colletti, L. M., Remick, D. G., Burtch, G. D., Kunkel, S. L., Strieter, R. M., Campbell Jr., D. A. (1990) Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J. Clin. Invest. 85, 1936-1943.
80. Vargas, F., Vives-Pi, M., Somoza, N., Armengol, P., Alcalde, L., Marti, M., Costa, M., Serradell, L., Dominguez, O., Fernandez-Llamazares, J., Julian, J. F., Sanmarti, A., Pujol-Borrell, R. (1998) Endotoxin contamination may be responsible for the unexplained failure of human pancreatic islet transplantation. Transplantation 65, 722-727.
81. Gray, D. W., Sutton, R., McShane, P., Peters, M., Morris, P. J. (1988) Exocrine contamination impairs implantation of pancreatic islets transplanted beneath the kidney capsule. J. Surg. Res. 45, 432-442.
82. Kolb, H., Burkart, V., Appels, B., Hanenberg, H., Kantwerk-Funke, G., Kiesel, U., Funda, J., Schraermeyer, U., Kolb-Bachofen, V. (1990) Essential contribution of macrophages to islet cell destruction in vivo and in vitro. J. Autoimmun. 3 (Suppl. 1), 117-120.
83. Schwizer, R. W., Leiter, E. H., Evans, R. (1984) Macrophage-mediated cytotoxicity against cultured pancreatic islet cells. Transplantation 37, 539-544.
84. Heitmeier, M. R., Scarim, A. L., Corbett, J. A. (1997) Interferon-γ increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1. J. Biol. Chem. 272, 13697-13704.
85. Arnush, M., Heitmeier, M. R., Scarim, A. L., Marino, M. H., Manning, P. T., Corbett, J. A. (1998) IL-1 produced and released endogenously within human islets inhibits β cell function. J. Clin. Invest. 102, 516-526.
86. Heitmeier, M. R., Scarim, A. L., Corbett, J. A. (1999) Double-stranded RNA inhibits β-cell function and induces islet damage by stimulating β-cell production of nitric oxide. J. Biol. Chem. 274, 12531-12536.
87. Lacy, P. E., Finke, E. H. (1991) Activation of intraislet lymphoid cells causes destruction of islet cells. Am. J. Pathol. 138, 1183-1190.
88. Lifson, N., Kramlinger, K. G., Mayrand, R. R., Lender, E. J. (1980) Blood flow to the rabbit pancreas with special reference to the islets of Langerhans. Gastroenterology 79, 466-473.
89. Jansson, L., Hellerstrom, C. (1983) Stimulation by glucose of the blood flow to the pancreatic islets of the rat. Diabetologia 25, 45-50.
90. Stagner, J. I., Mokshagundam, S., Samols, E. (1995) Hormone secretion from transplanted islets is dependent upon changes in islet revascularization and islet architecture. Transplant. Proc. 27, 3251-3254.
91. Walsh, T. J., Eggleston, J. C., Cameron, J. L. (1982) Portal hypertension, hepatic infarction, and liver failure complicating pancreatic islet autotransplantation. Surgery 91, 485-487.
92. Griffith, R. C., Scharp, D. W., Hartman, B. K., Ballinger, W. F., Lacy, P. E. (1977) A morphologic study of intrahepatic portal-vein islet isografts. Diabetes 26, 201-214.
93. Stagner, J. I., Samols, E. (1990) The induction of capillary bed development by endothelial cell growth factor before islet transplantation may prevent islet ischemia. Transplant. Proc. 22, 824-828.
94. Parr, E. L., Bowen, K. M., Lafferty, K. J. (1980) Cellular changes in cultured mouse thyroid glands and islets of Langerhans. Transplantation 30, 135-141.
95. Vasir, B., Aiello, L. P., Yoon, K. H., Quickel, R. R., Bonner-Weir, S., Weir, G. C. (1998) Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes 47, 1894-1903.
96. Vajkoczy, P., Olofsson, A. M., Lehr, H. A., Leiderer, R., Hammersen, F., Arfors, K. E., Menger, M. D. (1995) Histogenesis and ultrastructure of pancreatic islet graft microvasculature. Evidence for graft revascularization by endothelial cells of host origin. Am. J. Pathol. 146, 1397-1405.
97. Vajkoczy, P., Menger, M. D., Simpson, E., Messmer, K. (1995) Angiogenesis and vascularization of murine pancreatic islet isografts. Transplantation 60, 123-127.
98. Merchant, F. A., Diller, K. R., Aggarwal, S. J., Bovik, A. C. (1997) Angiogenesis in cultured and cryopreserved pancreatic islet grafts. Transplantation 63, 1652-1660.
99. Sezai, S., Sakurabayashi, S., Yamamoto, Y., Morita, T., Hirano, M., Oka, H. (1993) Hepatic arterial and portal venous oxygen content and extraction in liver cirrhosis. Liver 13, 31-35.
100. Carlsson, P. O., Liss, P., Andersson, A., Jansson, L. (1998) Measurements of oxygen tension in native and transplanted rat pancreatic islets. Diabetes 47, 1027-1032.
101. Carlsson, P. O., Palm, F., Andersson, A., Liss, P. (2001) Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 50, 489-495.
102. Carlsson, P. O., Palm, F. (2002) Oxygen tension in isolated transplanted rat islets and in islets of rat whole-pancreas transplants. Transpl. Int. 15, 581-585.
103. Carlsson, P. O., Palm, F., Andersson, A., Liss, P. (2000) Chronically decreased oxygen tension in rat pancreatic islets transplanted under the kidney capsule. Transplantation 69, 761-766.
104. Dionne, K. E., Colton, C. K., Yarmush, M. L. (1993) Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes 42, 12-21.
105. Davalli, A. M., Scaglia, L., Zangen, D. H., Hollister, J., Bonner-Weir, S., Weir, G. C. (1996) Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 45, 1161-1167.
106. Han, D. J., Kim, S. C., Wee, Y. M. (2003) Central cell death in isolated pancreatic islets is inherent to their spherical structure. Transplantation 76 (Suppl. 4), S67-S68.
107. Juang, J. H., Hsu, B. R., Kuo, C. H., Uengt, S. W. (2002) Beneficial effects of hyperbaric oxygen therapy on islet transplantation. Cell Transplant. 11, 95-101.
108. Parks, D. A., Granger, D. N. (1986) Contributions of ischemia and reperfusion to mucosal lesion formation. Am. J. Physiol. 250, G749-G753.
109. Korthuis, R. J., Smith, J. K., Carden, D. L. (1989) Hypoxic reperfusion attenuates postischemic microvascular injury. Am. J. Physiol. 256, H315-H319.
110. Thurman, R. G., Marzi, I., Seitz, G., Thies, J., Lemasters, J. J., Zimmerman, F. (1988) Hepatic reperfusion injury following orthotopic liver transplantation in the rat. Transplantation 46, 502-506.
111. Carden, D. L., Granger, D. N. (2000) Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 190, 255-266.
112. Adams, D. H., Hubscher, S. G., Shaw, J., Rothlein, R., Neuberger, J. M. (1989) Intercellular adhesion molecule 1 on liver allografts during rejection. Lancet 2, 1122-1125.
113. Ichikawa, H., Flores, S., Kvietys, P. R., Wolf, R. E., Yoshikawa, T., Granger, D. N., Aw, T. Y. (1997) Molecular mechanisms of anoxia/reoxygenation- induced neutrophil adherence to cultured endothelial cells. Circ. Res. 81, 922-931.
114. Arai, K., Sunamura, M., Wada, Y., Takahashi, M., Kobari, M., Kato, K., Yagita, H., Okumura, K., Matsuno, S. (1999) Preventing effect of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies on murine islet allograft rejection. Int. J. Pancreatol. 26, 23-31.
115. Katz, S. M., Bennett, F., Stecker, K., Clark, J. H., Pham, T., Wang, M. E., Kahan, B. D., Stepkowski, S. M. (2000) ICAM-1 antisense oligodeoxynucleotide improves islet allograft survival and function. Cell Transplant. 9, 817-828,
116. Augstein, P., Dunger, A., Heinke, P., Wachlin, G., Berg, S., Hehmke, B., Salzsieder, E. (2003) Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-γ expression in splenic T cells. Biochem. Biophys. Res. Commun. 304, 378-384.
117. Chakrabarti, D., Huang, X., Beck, J., Henrich, J., McFarland, N., James, R. F., Stewart, T. A. (1996) Control of islet intercellular adhesion molecule-1 expression by interferon-α and hypoxia. Diabetes 45, 1336-1343.
118. Piemonti, L., Leone, B. E., Nano, R., Saccani, A., Monti, P., Maffi, P., Bianchi, G., Sica, A., Peri, G., Melzi, R., Aldrighetti, L., Secchi, A., Di Carlo, V., Allavena, P., Bertuzzi, F. (2002) Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 51, 55-65.
119. Baker, M. S., Chen, X., Rotramel, A., Nelson, J., Kaufman, D. B. (2003) Proinflammatory cytokines induce NF-κB-dependent/NO-independent chemokine gene expression in MIN6 β cells. J. Surg. Res. 110, 295-303.
120. Hanahan, D. J. (1986) Platelet activating factor: a biologically active phosphoglyceride. Annu. Rev. Biochem. 55, 483-509.
121. Carlsen, E., Flatmark, A., Prydz, H. (1988) Cytokine-induced procoagulant activity in monocytes and endothelial cells. Further enhancement by cyclosporine. Transplantation 46, 575-580.
122. Ogawa, S., Gerlach, H., Esposito, C., Pasagian-Macaulay, A., Brett, J., Stern, D. (1990) Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J. Clin. Invest. 85, 1090-1098.
123. Yoshimura, N., Kobayashi, Y., Nakamura, K., Yoshimura, R., Yamagishi, H., Oka, T. (1998) Role of tissue factor in ischemic reperfusion injury: iv). The effect of tissue factor pathway inhibitor on the survival rate in vivo. Transplant. Proc. 30, 2300-2301.
124. Morrissey, J. H. (2004) Tissue factor: a key molecule in hemostatic and nonhemostatic systems. Int. J. Hematol. 79, 103-108.
125. Nawroth, P. P., Stern, D. M. (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J. Exp. Med. 163, 740-745.
126. Moberg, L., Johansson, H., Lukinius, A., Berne, C., Foss, A., Kallen, R., Ostraat, O., Salmela, K., Tibell, A., Tufveson, G., Elgue, G., Nilsson, E. K., Korsgren, O., Nilsson, B. (2002) Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 360, 2039-2045.
127. Sever, C. E., Demetris, A. J., Zeng, Y., Tzakis, A., Fung, J. J., Starzl, T. E., Ricordi, C. (1992) Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants. Am. J. Pathol. 140, 1255-1260.
128. Arai, M., Mochida, S., Ohno, A., Fujiwara, K. (1996) Blood coagulation in the hepatic sinusoids as a contributing factor in liver injury following orthotopic liver transplantation in the rat. Transplantation 62, 1398-1401.
129. Cywes, R., Packham, M. A., Tietze, L., Sanabria, J. R., Harvey, P. R., Phillips, M. J., Strasberg, S. M. (1993) Role of platelets in hepatic allograft preservation injury in the rat. Hepatology 18, 635-647.
130. Bennet, W., Sundberg, B., Groth, C. G., Brendel, M. D., Brandhorst, D., Brandhorst, H., Bretzel, R. G., Elgue, G., Larsson, R., Nilsson, B., Korsgren, O. (1999) Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 48, 1907-1914.
131. Ozmen, L., Ekdahl, K. N., Elgue, G., Larsson, R., Korsgren, O., Nilsson, B. (2002) Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 51, 1779-1784.
132. Starzl, T. E., Francavilla, A., Halgrimson, C. G., Francavilla, F. R., Porter, K. A., Brown, T. H., Putnam, C. W. (1973) The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg. Gynecol. Obstet. 137, 179-199.
133. Hirshberg, B., Mog, S., Patterson, N., Leconte, J., Harlan, D. M. (2002) Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using Edmonton protocol immunosuppression. J. Clin. Endocrinol. Metab. 87, 5424-5429.
134. Ryan, E. A., Lakey, J. R., Rajotte, R. V., Korbutt, G. S., Kin, T., Imes, S., Rabinovitch, A., Elliott, J. F., Bigam, D., Kneteman, N. M., Warnock, G. L., Larsen, I., Shapiro, A. M. (2001) Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50, 710-719.
135. Curran, R. D., Billiar, T. R., Stuehr, D. J., Hofmann, K., Simmons, R. L. (1989) Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J. Exp. Med. 170, 1769-1774.
136. Tenhunen, R., Marver, H. S., Schmid, R. (1968) The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. USA 61, 748-755.
137. Rizzardini, M., Terao, M., Falciani, F., Cantoni, L. (1993) Cytokine induction of haem oxygenase mRNA in mouse liver. Interleukin 1 transcriptionally activates the haem oxygenase gene. Biochem. J. 290, 343-347.
138. Durante, W., Kroll, M. H., Christodoulides, N., Peyton, K. J., Schafer, A. I. (1997) Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ. Res. 80, 557-564.
139. Tobiasch, E., Gunther, L., Bach, F. H. (2001) Heme oxygenase-1 protects pancreatic β cells from apoptosis caused by various stimuli. J. Investig. Med. 49, 566-571.
140. Ye, J., Laychock, S. G. (1998) A protective role for heme oxygenase expression in pancreatic islets exposed to interleukin-1β. Endocrinology 139, 4155-4163.
141. Pileggi, A., Molano, R. D., Berney, T., Cattan, P., Vizzardelli, C., Oliver, R., Fraker, C., Ricordi, C., Pastori, R. L., Bach, F. H., Inverardi, L. (2001) Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50, 1983-1991.
142. Ribeiro, M. M., Klein, D., Pileggi, A., Molano, R. D., Fraker, C., Ricordi, C., Inverardi, L., Pastori, R. L. (2003) Heme oxygenase-1 fused to a TAT peptide transduces and protects pancreatic β-cells. Biochem. Biophys. Res. Commun. 305, 876-881.
143. Stocker, R., Yamamoto, Y., McDonagh, A. F., Glazer, A. N., Ames, B. N. (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043-1046.
144. Gunther, L., Berberat, P. O., Haga, M., Brouard, S., Smith, R. N., Soares, M. P., Bach, F. H., Tobiasch, E. (2002) Carbon monoxide protects pancreatic β-cells from apoptosis and improves islet function/survival after transplantation. Diabetes 51, 994-999.
145. Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao, L. H., Wysk, M., Davis, R. J., Flavell, R. A., Choi, A. M. (2000) Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6, 422-428.
146. Balasa, B., Van Gunst, K., Jung, N., Katz, J. D., Sarvetnick, N. (2000) IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide- induced diabetes in the nonobese diabetic mouse. Cell. Immunol. 202, 97-102.
147. Pennline, K. J., Roque-Gaffney, E., Monahan, M. (1994) Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71, 169-175.
148. Zhang, Y. C., Pileggi, A., Agarwal, A., Molano, R. D., Powers, M., Brusko, T., Wasserfall, C., Goudy, K., Zahr, E., Poggioli, R., Scott-Jorgensen, M., Campbell-Thompson, M., Crawford, J. M., Nick, H., Flotte, T., Ellis, T. M., Ricordi, C., Inverardi, L., Atkinson, M. A. (2003) Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice. Diabetes 52, 708-716.
149. Smith, D. K., Korbutt, G. S., Suarez-Pinzon, W. L., Kao, D., Rajotte, R. V., Elliott, J. F. (1997) Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent β cell destruction in diabetic NOD mice. Transplantation 64, 1040-1049.